Global Medical Cannabis Market, by Alzheimer’s Disease ,

the global medical cannabis market is witnessing a significant rise in demand, driven by the increasing prevalence of alzheimer's disease. alzheimer's disease is a progressive brain disorder that affects a person's memory, thinking, and behavior. it is the most common form of dementia, accounting for 60-80% of cases. according to the alzheimer's association, it is estimated that 5.8 million americans aged 65 and older are living with alzheimer's, and this number is projected to reach 13.8 million by 2050. alzheimer's disease is a complex condition that currently has no cure. the available treatments only aim to manage the symptoms and slow down the progression of the disease. however, these treatments have limitations and come with various side effects. this is where medical cannabis comes into the picture as a potential alternative treatment option. medical cannabis, also known as medical marijuana, is a term used to refer to the use of the cannabis plant for medicinal purposes. it contains chemical compounds called cannabinoids, which are believed to have therapeutic effects. these compounds interact with the body's endocannabinoid system, which is responsible for regulating various physiological functions, including memory, mood, and pain sensation. recent studies have shown that medical cannabis may have potential benefits for alzheimer's disease. one of the main compounds found in cannabis, tetrahydrocannabinol (thc), has been found to have neuroprotective properties. it can help reduce the production of beta-amyloid plaques, which are considered one of the main hallmarks of alzheimer's disease. these plaques are thought to contribute to the degeneration of brain cells and the formation of neurofibrillary tangles, leading to memory loss and cognitive decline. in addition to its neuroprotective effects, medical cannabis may also help manage some of the symptoms associated with alzheimer's disease. these include agitation, anxiety, sleep problems, and depression. many patients have reported improvements in their quality of life and a reduction in symptoms after using medical cannabis. the increasing demand for medical cannabis for alzheimer's disease has led to the growth of the global market. several countries have legalized the use of medical cannabis, and companies are investing in research and development to create more effective and safe treatments. however, it is essential to note that further studies are needed to fully understand the potential benefits and risks of medical cannabis for alzheimer's disease. nonetheless, the demand for this alternative treatment option is expected to continue to grow as the global population ages and the prevalence of alzheimer's disease continues to rise.